Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compound and method for treating myotonic dystrophy

Compound and method for treating myotonic dystrophy

US Patent 11236329 · Granted Feb 1, 2022

Estimated economic value: $33,446,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oligonucleotide analogues targeting human LMNA2023
Oligonucleotide analogues targeting human LMNA2021
Compound and method for treating myotonic dystrophy2021
Compositions for enhancing transport of molecules into cells2021
Oligonucleotide analogues targeting human LMNA2020
Methods for treating progeroid laminopathies using oligonucleotide analogues tar2019
Compositions for enhancing transport of molecules into cells2019
Compound and method for treating myotonic dystrophy2018
Oligonucleotide analogues targeting human LMNA2018
Methods for treating progeroid laminopathies using oligonucleotide analogues tar2017
Oligonucleotide analogues targeting human LMNA2017
Compositions for enhancing transport of molecules into cells2017